insights_auto
Why is EDIT down 13.82%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.87
arrow_downward
-13.82%(-0.30) 1D
$1.91
arrow_upward
+2.14% (+0.040)bedtimeAfter hours
Closed: Nov 16, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.10
High
$2.12
Low
$1.86
Mkt. cap
288.62M
Avg. vol.
2.44M
Volume
2.11M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$2.10
High
$2.12
Low
$1.86
Mkt. cap
288.62M
Avg. vol.
2.44M
Volume
2.11M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
Stocktwits
·
1 hour ago
S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
ChartMill
·
5 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
BigGo Finance
·
11 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
57 minutes ago
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com